Illumina raises target price to $300 from $225
ILMN•Stifel raised its target price for Illumina to $300 from $225.
Related News
Intensity Therapeutics schedules third-quarter financial results release
INTS•
IntelliCheck publishes update to financial calendar
IDN•
Currenc reinstates Tranglo sale agreement with New Margin
CURR•
Genius Sports expands AFA partnership to bring faster offside decisions to Argentine football
GENI•
OmniAb reports third-quarter 2026 financial results and business highlights
OABI•